DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $76.09, for a total transaction of $608,720.00. Following the completion of the transaction, the chief financial officer now owns 86,156 shares in the company, valued at approximately $6,555,610.04. This trade represents a 8.50 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Blake Jeffrey Grayson also recently made the following trade(s):
- On Wednesday, March 19th, Blake Jeffrey Grayson sold 16,111 shares of DocuSign stock. The stock was sold at an average price of $83.20, for a total transaction of $1,340,435.20.
- On Friday, February 14th, Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock. The stock was sold at an average price of $86.90, for a total transaction of $695,200.00.
DocuSign Stock Performance
Shares of DOCU traded down $1.10 during trading hours on Wednesday, hitting $76.39. The company had a trading volume of 2,310,353 shares, compared to its average volume of 2,725,731. The firm has a fifty day moving average price of $82.19 and a 200-day moving average price of $82.95. The stock has a market capitalization of $15.47 billion, a price-to-earnings ratio of 15.75, a P/E/G ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the company. JMP Securities reaffirmed a “market outperform” rating and set a $124.00 price target on shares of DocuSign in a research note on Tuesday, January 7th. Wedbush restated a “neutral” rating and issued a $100.00 target price on shares of DocuSign in a research report on Friday, March 14th. Jefferies Financial Group reduced their price target on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating on the stock in a research report on Monday, March 31st. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Friday, March 14th. Finally, Bank of America decreased their target price on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating on the stock in a research report on Friday, March 14th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $93.46.
Check Out Our Latest Analysis on DOCU
Institutional Trading of DocuSign
A number of institutional investors have recently made changes to their positions in the stock. Rhumbline Advisers lifted its holdings in shares of DocuSign by 118.8% during the 4th quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock valued at $54,695,000 after buying an additional 330,136 shares during the period. KBC Group NV grew its stake in shares of DocuSign by 32.7% during the 4th quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock valued at $138,067,000 after purchasing an additional 378,233 shares during the period. Jennison Associates LLC purchased a new stake in shares of DocuSign during the 4th quarter valued at about $12,897,000. Everence Capital Management Inc. purchased a new position in shares of DocuSign in the fourth quarter worth approximately $720,000. Finally, Principal Financial Group Inc. increased its holdings in DocuSign by 3,026.7% during the fourth quarter. Principal Financial Group Inc. now owns 546,796 shares of the company’s stock valued at $49,179,000 after buying an additional 529,308 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- How to Find Undervalued Stocks
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Golden Cross Stocks: Pattern, Examples and Charts
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- What is the Euro STOXX 50 Index?
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.